SOPHiA GENETICS analyzes one million genomic profiles
Having facilitated the analysis of one million genomic profiles, the SOPHiA DDM™ Platform has been exposed to a highly diverse array of genomic variants needed to continually hone machine learning algorithms for the accurate detection of rare and challenging cases.
J.P. Morgan Global Technology, Media, and Communications Conference
SOPHiA GENETICS to Attend and Host Investor Meetings at the J.P. Morgan 50th Annual Global Technology, Media, and Communications Conference
Check out our Science Hub
Get a closer look at the science behind what makes SOPHiA GENETICS technology unique.
Evolution of Precision Medicine
This blog examines the evolution of precision medicine and how we can achieve its promise.
Discover how we are unlocking the promise of data-driven medicine in cancer care, together. Register now to attend and receive updates about our ASCO presence.
In The News
Inside Precision Medicine
SOPHiA GENETICS’ Data Driven Medicine Platform Hits One Million Genomic Profiles
SOPHiA GENETICS Hits Milestone Of One Million Genomic Profiles Analyzed By The SOPHiA DDM Platform
AI Applications Address Challenges in Cancer Patient Screening
Q: What important company milestone do you anticipate reaching in 2022?
Q: What’s the key to being a leader in the industry?